GPP
CALA

Great Point Partners’s Calithera Biosciences, Inc CALA Stock Holding History

Great Point Partners’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-92,250
Closed -$9.06M – 43
2020
Q4 		$9.06M Sell
92,250
-53,679
-37% -$4.7M 1.47% 23
2020
Q3 		$10.1M Buy
145,929
+32,844
+29% +$2.87M 0.91% 26
2020
Q2 		$11.9M Buy
+113,085
New +$13.4M 0.95% 26

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Great Point Partners's CALA Position: Q1 2021 in Review

Great Point Partners sold out of Calithera Biosciences, Inc (CALA) in Q1 2021, closing a stake of 92,250 shares — an estimated $9.06M sold.

Great Point Partners first reported a position in CALA in Q2 2020 and held it in 3 quarters. The position peaked at $11.9M in Q2 2020. 100 funds tracked by Wall St. Rank hold CALA as of Q1 2021.

  • Great Point Partners reported no remaining Calithera Biosciences, Inc position as of Q1 2021 after selling out during the quarter.
  • Great Point Partners sold 92,250 Calithera Biosciences, Inc shares in Q1 2021, an estimated $9.06M.
  • Great Point Partners first reported a position in Calithera Biosciences, Inc in Q2 2020 and held it in 3 quarters.
  • Great Point Partners's Calithera Biosciences, Inc position peaked at $11.9M in Q2 2020.
  • 100 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2021.

Based on Great Point Partners's 13F filing for Q1 2021, filed 17 May 2021.